UC Davis Midtown Ambulatory Care Centre
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Medici, Valentina
GATEWAY, NCT04537377 / 2020-000963-22: A Phase I/II Study of VTX-801 in Adult Patients With Wilson's Disease

Active, not recruiting
1/2
4
Europe, US
VTX-801
Vivet Therapeutics SAS
Wilson's Disease
12/24
06/29
NCT04884815 / 2020-005266-34: Study of UX701 Gene Transfer for the Treatment of Wilson Disease

Active, not recruiting
1/2
78
Europe, Canada, US
UX701, Placebo
Ultragenyx Pharmaceutical Inc, Ultragenyx Pharmaceutical Inc.
Wilson Disease
08/26
11/31
NCT02754037: Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study

Active, not recruiting
N/A
120
US
Fluorodeoxyglucose (FDG) positron emission tomography (PET), Magnetic resonance imaging (MRI), Magnetic resonance proton density fat fraction (MR-PDFF), Magnetic resonance elastography (MRE), PET Explorer
University of California, Davis, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH)
06/25
06/25
REASON, NCT05783687: Real World Evidence Study in Subjects With Wilson's Disease

Active, not recruiting
N/A
50
US
NCC-Sp Assay
Orphalan
Wilson Disease
12/25
12/25

Download Options